

Publisher: Spandidos Publications
E-ISSN: 1791-2431|35|2|1170-1178
ISSN: 1021-335X
Source: Oncology Reports, Vol.35, Iss.2, 2016-01, pp. : 1170-1178
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Cisplatin regulates SH-SY5Y cell growth through downregulation of BDNF via miR-16
Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. :





